References
- McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488–1491.
- Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491–1493.
- Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature. 2007;488:353–357.
- Tucker NR, Clauss S, Ellinor PT. Common variation in atrial fibrillation: navigating the path from genetic association to mechanism. Cardiovasc Res. 2016;109:493–501.
- Gudbjartsson DF, Holm H, Gretarsdottir S, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet. 2009;41:876–888.
- Helgadottir A, Thorleifsson G, Magnusson KP, et al. The same sequence variant on 9q21 associates myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008;40:217–224.
- Holm H, Gudbjartsson DF, Sulem P, et al. A rare variant in MYH6 is associated with high risk of sick sinus syndrome. Nat Genet. 2011;43:316–320.
- Gudbjartsson DF, Helgason H, Gudjonsson SA, et al. Large-scale whole-genome sequencing of the Icelandic population. Nat Genet. 2015;47:435–444.
- Sulem P, Helgason H, Oddsson A, et al. Identification of a large set of rare complete human knockouts. Nat Genet. 2015;47:448–452.
- Helgason A, Sigurdardottir S, Gulcher J, et al. mtDNA and the origin of the icelanders: deciphering signals of recent population history. Am J Hum Genet. 2000;66:999–1016.
- Arnar DO, Thorvaldsson S, Manolio T, et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J. 2006;27:708–712.
- Fox CS, Parise H, D’Agostino RB, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA. 2004;291:2851–2855.
- Mommersteeg MT, Brown NA, Prall OW, et al. PITX2c and NKX2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res. 2007;101:902–909.
- Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–666.
- Mabuchi M, Kataoka H, Miura Y, et al. Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction. Biochem Biophys Res Commun. 2010;398:321–325.
- Darbar D, Roden DM. Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nat Rev Cardiol. 2013;10:317–329.
- Ellinor P, Lunetta KL, Glazer NL, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet. 2010;42:240–244.
- Ellinor PT, Lunetta KL, Albert CM, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012;44:670–675.
- Holm H, Gudbjartsson DF, Arnar DO, et al. Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet. 2010;42:117–122.
- Chambers JC, Zhao J, Terracciano CMN, et al. Genetic variation in SCN10A influences cardiac conduction. Nat Genet. 2010;42:149–152.
- Pfeufer A, van Noord C, Marciante KD, et al. Genome-wide association study of PR interval. Nat Genet. 2010;42:153–159.
- Gudbjartsson DF, Holm H, Sulem P, et al. A frameshift mutation in the sarcomere gene MYL4 causes early onset familial atrial fibrillation. Eur Heart J. 2016. [Epub ahead of print]. doi: 10.1093/eurheartj/ehw379.
- Björkegren JLM, Kovacic JC, Dudley JT, et al. Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. J Am Coll Cardiol. 2015;65:830–845.
- Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677–687.
- Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40:161–169.
- Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206.
- CardiogramplusC4D Consortium, Delouskas P, Kanoni S, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25–33.
- Samani NJ, Endman J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–453.
- Helgadottir A, Gretarsdottir S, Thorleifsson G, et al. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol. 2012;60:722–729.
- Bjornsson E, Gudbjartsson DF, Helgadottir A, et al. Common sequence variants associated with coronary artery disease associate with the extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:1526–1531.
- Nioi P, Sigurdsson A, Thorleifsson H, et al. Variant ASGR1 associated with a reduced risk of coronary artery disease. N Engl J Med. 2016;374:2131–2141.
- Helgadottir A, Gretarsdottir S, Thorleifsson G, et al. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease. Nat Genet. 2016;48:634–639.
- Roberts R. Genetics of coronary artery disease. Circ Res. 2014;114:1890–1903.
- Collins FS, Varmus H. A new initative on precision medicine. N Eng J Med. 2015;379:793–795.
- King MC, Levy-Lahad E, Lahad A. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA. 2014;312:1091–1092.
- Editorial. Letters from Iceland. Nat Genet. 2015;47:425.
- Wilde AA, Behr ER. Genetic testing for inherited cardiac disease. Nat Rev Cardiol. 2013;10:571–583.